phase readout
saveNCT06043427: Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
RECRUITINGupdated 17d ago
community read0 votes
Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Gastroesophageal Adenocarcinoma
view source ↗
comments(0)
5-min edit window · permanent after that